Hypocalcemia is most commonly seen within the first six months of GLP-1 receptor agonist therapy, while hypercalcemia is noted to occur after at least six months of therapy
Regarding neuroplasticity regulation, suppressed Notch/DNER signaling and dysregulated Wnt/AXIN1 pathway may compromise hippocampal neurogenesis [26, 53, 54], while disrupted NTRK2-BDNF signaling and impaired Nr-CAM-mediated cell adhesion could lead to decreased synaptophysin synthesis and dendritic complexity [55]
They're signaling molecules that encourage repair and barrier support, not surface exfoliants
Dao-Chi powder ameliorates pancreatitis-induced intestinal and cardiac injuries via regulating the Nrf2-HO-1-HMGB1 signaling pathway in rats
Most clinical experience involves short-term therapies, typically for less than a year
PMID: 18416885 Zdzieblik D, et al